BioMarker Strategies Revenue

Biotechnology Research • Derwood, Maryland, United States • 1-10 Employees

BioMarker Strategies revenue & valuation

Annual revenue	$58,300,000
Revenue per employee	$19,427,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$186,500,000
Total funding	$525,000

Key Contact at BioMarker Strategies

Jerry Parrott

President and CEO

Company overview

Headquarters	15601 Crabbs Branch Way, Rockville, MD 20855, US
Phone number	+14105221009
Website	biomarkerstrategies.com
NAICS	541714
SIC	873
Founded	2007
Employees	1-10
Socials

About BioMarker Strategies

BioMarker Strategies has developed the proprietary SnapPath® Cancer Diagnostics System for predictive tests to guide targeted drug development and treatment selection for patients with solid tumor malignancies. Our mission is to make personalized medicine more of a reality for these patients. SnapPath® is unique in automating and standardizing functional ex vivo profiling to capture the dynamic and predictive signaling information available only from live solid tumor cells. Our PathMAP® Functional Signaling Profiles, created using the SnapPath® system, represent a new class of biomarker tests that are highly predictive of individual response to targeted treatments for solid tumors, because they are based on information available only from live cells. Our business development efforts are directed toward entering into funded collaborations with companies developing targeted therapies for patients with solid tumors. The capabilities of SnapPath® and the Functional Profiles it enables are available for Research Use in preclinical studies in tumorgraft and other model systems, and in early clinical studies to assess pharmacodynamic changes in the solid tumors of individual patients.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

BioMarker Strategies has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore BioMarker Strategies's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2016-10-06	1	$525,000

Funding Insights

$525,000

Total funding amount

$525,000

Most recent funding amount

Number of funding rounds

BioMarker Strategies Tech Stack

Discover the technologies and tools that power BioMarker Strategies's digital infrastructure, from frameworks to analytics platforms.

Windows Server

Operating systems

Sectigo

SSL/TLS certificate authorities

IIS

Web servers

Microsoft ASP.NET

Web frameworks

Google Maps

Maps

Microsoft 365

Frequently asked questions

BioMarker Strategies is located in Derwood, Maryland, US.

You can reach BioMarker Strategies at +14105221009.

BioMarker Strategies generates an estimated annual revenue of $58,278,832. This revenue figure reflects the company's market position and business performance in its industry.

BioMarker Strategies has an estimated valuation of $186,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

BioMarker Strategies was founded in 2007, making it 19 years old. The company has established itself as a significant player in its industry over this time.

BioMarker Strategies has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

BioMarker Strategies has raised a total of $525,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at BioMarker Strategies

Jerry Parrott

President and CEO

4.8

40,000 users